FSA Advisors’s Johnson & Johnson JNJ Stock Holding History

FSA Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$830K	Sell	3,266 -54	-2%	-$12.6K	0.38%	82
2026 Q1	$811K	Buy	+3,320	New	+$773K	0.53%	62
2025 Q4	–	Sell	-2,190	Closed	-$406K	–	231
2025 Q3	$406K	Buy	+2,190	New	+$375K	0.32%	88
2025 Q2	–	Sell	-1,210	Closed	-$201K	–	191
2025 Q1	$201K	Sell	1,210 -630	-34%	-$98.6K	0.16%	175
2024 Q4	$266K	Buy	+1,840	New	+$285K	0.33%	105

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FSA Advisors's JNJ Position: Q2 2026 in Review

FSA Advisors reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $12.6K and leaving 3,266 shares worth $830K. The position accounts for 0.38% of the portfolio, ranked #82.

FSA Advisors first reported a position in JNJ in Q4 2024 and has held it in 5 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

FSA Advisors held 3,266 shares of Johnson & Johnson worth $830K as of Q2 2026.
FSA Advisors sold 54 Johnson & Johnson shares in Q2 2026, an estimated $12.6K.
Johnson & Johnson made up 0.38% of FSA Advisors's portfolio in Q2 2026, its #82 holding.
FSA Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 5 quarters since.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on FSA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.